Skip to main content

brimonidine

Generic: BRIMONIDINE TARTRATE·Brand: ALPHAGAN, ALPHAGAN P, BRIMONIDINE TARTRATE, LUMIFY, LUMIFY PRESERVATIVE FREE, Lumify, MIRVASO, QOLIANA

brimonidine: developed by 1 company · 1 clinical trial tracked · 1 FDA decision.

brimonidine evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect brimonidine to RDY; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could brimonidine → RDY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors

Related indications

Eye DiseasesPresbyopia
Development Pipeline (1)
CompanyPhase
DR REDDYS LABORATORIES LTD (RDY)Approved
Clinical Trials (1)

A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

NCT05656027·Phase 3·LENZ
Completed

Primary endpoint: Percentage of Participants With a ≥ 3-line Improvement in Near Vision and no Loss ≥ 5 Letters Distance Vision

InterventionalRandomizedquadruple469 enrolledStarted 2022-12Completion 2024-0125 sites · United StatesLENZ Therapeutics, Inc
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution(RDY)FDA ↗
ANDA216361UNKNOWNStandardOphthalmicSolution/Drops

Frequently asked questions

Who is developing brimonidine?

brimonidine is being developed by DR REDDYS LABORATORIES LTD.

How many clinical trials involve brimonidine?

BioSniper tracks 1 clinical trial involving brimonidine.

What is brimonidine's latest FDA decision?

The most recent tracked FDA decision for brimonidine is Approval for 1 INDICATIONS AND USAGE Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution, dated February 16, 2024.